HVPG-BASED RISK STRATIFICATION IN PATIENTS WITH COMPENSATED NAFLD CIRRHOSIS

被引：0

作者：

Paternostro, Rafael ^{[1
]}

Kwanten, Wilhelmus J. ^{[2
]}

Bagdadi, Ali ^{[3
]}

Bauer, David ^{[4
]}

Becker, Jeannette ^{[1
]}

Hofer, Benedikt ^{[1
]}

Panagl, Vera ^{[1
]}

Schiffke, Helena ^{[1
]}

Vanwolleghem, Thomas ^{[5
]}

Vonghia, Luisa ^{[6
]}

Simbrunner, Benedikt ^{[4
]}

Jachs, Mathias ^{[7
]}

Hartl, Lukas ^{[7
]}

Schwabl, Philipp ^{[8
]}

Scheiner, Bernhard ^{[4
]}

Trauner, Michael H. ^{[4
]}

Mandorfer, Mattias ^{[4
]}

Reiberger, Thomas ^{[4
]}

Francque, Sven M. ^{[2
,9
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Antwerp Univ Hosp, Antwerp, Belgium

[3] Univ Ziekenhuis Antwerpen, Hepatol, Antwerp, Belgium

[4] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[5] Antwerp Univ Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium

[6] Univ Ziekenhuis Antwerpen, Antwerp, Belgium

[7] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[8] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria

[9] Univ Antwerp, Gastroenterol Hepatol, Antwerp, Belgium

来源：

HEPATOLOGY | 2021年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2052

引用

页码：1220A / 1221A

页数：2

共 50 条

[41] CHARACTERIZATION OF THE GUT MICROBIOTA BY QUANTITATIVE METAGENOMICS: A PROMISING TOOL FOR RISK STRATIFICATION IN NAFLD PATIENTS
Ratziu, V.
Pichaud, M.
Fedchuk, L.
Levenez, F.
Quinquis, B.
Galleron, N.
Batto, J-M.
Pons, N.
Le Chatelier, E.
Almeida, M.
Kennedy, S.
Dore, J.
Ehrlich, S. D.
Rimbaud, P.
JOURNAL OF HEPATOLOGY, 2013, 58 : S548 - S548
[42] Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination
Blank, Valentin
Petroff, David
Beer, Sebastian
Boehlig, Albrecht
Heni, Maria
Berg, Thomas
Bausback, Yvonne
Dietrich, Arne
Toenjes, Anke
Hollenbach, Marcus
Blueher, Matthias
Keim, Volker
Wiegand, Johannes
Karlas, Thomas
SCIENTIFIC REPORTS, 2020, 10 (01)
[43] CAN NON-INVASIVE TESTS (NIT) DETECT CHANGES IN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN PATIENTS WITH HEPATITIS C (HCV) COMPENSATED CIRRHOSIS?
Ortiz, Guillermo
Mohanty, Arpan
Sayyar, Mubarak
Jangouk, Parastoo
Gunabushanam, Gowthaman
Sheldon, Campbell
Deng, Yanhong
Ciarleglio, Maria
Garcia-Tsao, Guadalupe
HEPATOLOGY, 2019, 70 : 1237A - 1237A
[44] A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysis
Turco, L.
Villanueva, C.
La Mura, V.
Garcia-Pagan, J. C.
Reiberger, T.
Genesca, J.
Groszmann, R. J.
Sharma, B. C.
Merkel, C.
Bureau, C.
Alvarado, E.
Abraldes, J. G.
Albillos, A.
Banares, R.
Peck-Radosavljevic, M.
Augustin, S.
Sarin, S.
Bosch, J.
Garcia-Tsao, G.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S103 - S104
[45] RISK OF HEPATIC DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER (NAFLD)-RELATED CIRRHOSIS
Hernaez, Ruben
Yu, Xian
Kramer, Jennifer R.
El-Serag, Hashem B.
Kanwal, Fasiha
GASTROENTEROLOGY, 2019, 156 (06) : S1217 - S1218
[46] Hepatic venous pressure gradient (HVPG) measured at events is lower in non-alcoholic fatty liver disease (NAFLD) associated cirrhosis as compared to alcoholic cirrhosis
Skladany, Lubomir
Jancekova, Daniela
Zilincan, Michal
Okapec, Stanislav
Vnencakova, Janka
Selcanova, Svetlana Adamcova
Kukla, Michal
Koller, Tomas
JOURNAL OF HEPATOLOGY, 2022, 77 : S613 - S614
[47] The Presence of Ascites Affects the Predictive Value of HVPG on Early Rebleeding in Patients with Cirrhosis
Liu, Chuan
Shao, Ruoyang
Wang, Sining
Wang, Guangchuan
Wang, Lifen
Zhang, Mingyan
Liu, Yanna
Liang, Mingkai
Li, Xiaoguo
Kang, Ning
Wang, Jitao
Xu, Dan
Mao, Hua
Zhang, Chunqing
Qi, Xiaolong
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
[48] HEPATIC VENOUS-PRESSURE GRADIENT (HVPG) AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH CIRRHOSIS
BARRETT, G
BOSCH, J
GARCIATSAO, G
GROSZMANN, RJ
RICHARDSON, CR
NAVASA, M
RODES, J
CONN, HO
GRACE, ND
HEPATOLOGY, 1990, 12 (04) : 850 - 850
[49] Safety, risk stratification, and cost of ERCP in patients with cirrhosis: a prospective controlled study
Ahmed Attia
Egyptian Liver Journal, 14
[50] Safety, risk stratification, and cost of ERCP in patients with cirrhosis: a prospective controlled study
Attia, Ahmed
EGYPTIAN LIVER JOURNAL, 2024, 14 (01)

← 1 2 3 4 5 →